Abstract:
A method and device for determining whether an animal is infected with West Nile Virus (WN-V), or is either not infected or vaccinated with a WNV vaccine. The method includes contacting a biological sample from the subject with a first WNV polypeptide that is not an element of the WNV vaccine, and detecting whether antibodies in the sample bind to the WNV polypeptide. If the antibodies in the sample bind to the WNV polypeptide, it can be determined that the animal is naturally infected with WNV and if the antibodies do not bind to the polypeptide, it can be determined that the animal is either vaccinated or not infected.
Abstract:
Un polipéptido purificado que comprende SEQ ID NO: 12 o al menos 20 aminoácidos contiguos de SEQ ID NO: 12, en donde los al menos 20 aminoácidos contiguos se eligen entre los aminoácidos 16 a 150 o 209 a 240 de SEQ ID NO: 12.
Abstract:
The invention provides compositions and methods for the detection and quantification of A. phagocytophilum (formerly known as Ehrlichia equi) antibodies and antibody fragments.
Abstract:
A method and device for detecting a West Nile Virus (WNV) infection including contacting a biological sample from a subject with an anti-IgM antibody and a recombinant WNV E polypeptide and detecting whether the polypeptide substantially binds to an antibody in the sample. The invention also includes a method and device for determining whether an animal is infected with West Nile Virus (WNV), or is either not infected or is vaccinated with a WNV vaccine.
Abstract:
The invention provides compositions and methods for the detection and quantification of A. phagocytophila (formerly known as Erhlichia equi) antibodies and antibody fragments.
Abstract:
The invention provides compositions and methods for the detection and quantification of A. phagocytophilum (formerly known as Ehrlichia equi) antibodies and antibody fragments.